Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

University of Nouakchott | Mauritania

Author Profile

Scopus

ORCID ID

Dr. Mohamed Lemine Cheikh Brahim Ahmed

🎓Education :

  • PhD in Public Health 🧬
    Université Mohammed V, Rabat, Morocco
  • Master of Public Health in Molecular Epidemiology of Zoonotic Diseases 🦠🔬
    IAV Hassan II, Rabat, Morocco
  • Certificate in Molecular Biology and Bioinformatics 🧬💻
    Hua Zhong Normal University, Wuhan, China

🌍Professional Memberships :

  • Member of the World Society for Virology (WSV) 🧫
  • Member of the International Covid-19 Research Network (ICRN) 🦠
  • Member of the One Health Heukelbach Institute 🌱
  • Member of the MENA Coalition for HPV Elimination 💉
  • Member of the Research Unit on Molecular Epidemiology and Microorganism Diversity (EMDM) 🧬
  • President of the Mauritanian Society for Scientific Research (AMDRS) 🧑‍🔬
  • Collaborator on the Global Burden of Diseases (GBD) project, Institute for Health Metrics and Evaluation, University of Washington 🌎

💡Key Skills :

  • Vaccine Coordination & Logistics 🚚💉:

  • Planned and supervised vaccine logistics for remote regions in Mauritania, ensuring stock management and quality control practices for vaccines like PCV13 and Rotarix.
  • Public Health Communication & Training 📢👩‍⚕️:

  • Conducted team-building and training sessions for local health personnel, focusing on routine and Covid-19 vaccination campaigns.
  • Research Project Management 🧑‍🔬📊:

  • Led public health research projects, managing performance indicators, and reporting on vaccine distribution and health systems.
  • Flexibility & Versatility ⚙️:

  • Adapted to various challenges in vaccine distribution and epidemiological surveillance, especially during pandemics.

Main Qualifications :

Vaccination 💉:

  • Supervised and trained local teams for stock management and quality control of vaccines across remote areas in Mauritania.
  • Led national Covid-19 vaccination strategy development, training teams and evaluating the impact of vaccine introductions (e.g., PCV13, Rotarix).
  • Coordinated routine vaccination campaigns across all 15 regions of Mauritania and introduced critical vaccines like nVPO2 for polio.

Epidemiological Surveillance 🧬:

  • Developed and implemented national strategies for combatting Covid-19, including plans for testing diseases like measles, polio, hemorrhagic fevers, and HPV.
  • Organized and led sentinel surveillance programs for diseases like rotavirus and influenza.
  • Conducted performance evaluations of Mauritania’s health information systems and trained response teams for integrated epidemiological surveillance.

🏢Recent Professional Experience :

National Consultant

UNICEF, Mauritania (Feb 2022 – Jul 2022)
Supported cold chain logistics and vaccine management for poliomyelitis response campaigns. Key tasks included overseeing vaccine distribution, supporting data analysis, and participating in meetings for budget planning with GPEI.

  • Provided technical assistance for vaccine logistics, ensuring the collection and destruction of unusable vaccine vials.
  • Led training sessions for independent monitors and LQAS surveyors to evaluate the polio vaccination campaign.

📈 Conclusion🌟

Dr. Mohamed Lemine Cheikh Brahim Ahmed is a highly skilled expert in vaccination logistics and epidemiological surveillance 🦠💉, with extensive experience in public health, research management, and disease control. His work spans from developing national vaccination strategies, including Covid-19, to training teams and overseeing campaigns in remote regions of Mauritania. As a member of numerous global health organizations 🌍 and a key contributor to projects like the Global Burden of Diseases 🌎, he is committed to improving public health outcomes through innovative approaches and evidence-based strategies. Dr. Ahmed’s versatility, leadership, and dedication make him a valuable asset in the field of global health and vaccination efforts.

📊🔬NOTABLE PUBLICATION:

 

    • Article: Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis
      • Authors: Abou Ghayda, R., Lee, K.H., Han, Y.J., Smith, L., Shin, J.I.
      • Journal: Journal of Medical Virology
      • Year: 2022

     

    • Article: Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
      • Authors: Park, S.H., Hong, S.H., Kim, K., Il Shin, J., Smith, L.
      • Journal: Journal of Medical Virology
      • Year: 2023

     

    • Article: COVID-19 outbreak in Mauritania: Epidemiology and health system response
      • Authors: Ahmed, M.L.C.B., Zehaf, S., El Alem, M.M., Abdellahi, M.V.M., Heukelbach, J.
      • Journal: Journal of Infection in Developing Countries
      • Year: 2021

Dr. Francesco Raspagliesi – Gynecologic Oncology – Best Researcher Award

Dr. Francesco Raspagliesi - Gynecologic Oncology - Best Researcher Award

Fondazione IRCCS Istituto nazionale Tumori di Milano - Italy  

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Francesco Raspagliesi began his academic journey with a Degree in Medicine and Surgery from the University of Catania, Italy, which he completed on March 7, 1981. Following this foundational education, he obtained qualifications to practice medicine in 1981 and specialized in Obstetrics and Gynecology from the University of Catania in 1985 and 1988. These early academic pursuits laid the groundwork for his future professional endeavors in the field of gynecologic oncology.

PROFESSIONAL ENDEAVORS

From 1985 to 1992, Raspagliesi served as a Research Fellow at the Fondazione IRCCS Istituto Nazionale Tumori di Milano. He continued his professional growth at the same institution, becoming a Dirigente Medico di 1° Livello from 1992 to 1999 and advancing to Dirigente Medico di 2° Livello Gynecologic Oncology Unit Director from 1999 to 2019. His long-standing association with the Fondazione IRCCS Istituto Nazionale Tumori di Milano demonstrates his commitment and dedication to the field of gynecologic oncology and patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON GYNECOLOGIC ONCOLOGY

Throughout his career, Raspagliesi has made significant contributions to the field of Obstetrics and Gynecology. His research and clinical work have focused on gynecologic oncology, particularly in the treatment and management of gynecologic cancers. His expertise and leadership as the Gynecologic Oncology Unit Director have contributed to advancements in the diagnosis, treatment, and care of patients with gynecologic cancers.

IMPACT AND INFLUENCE

As a respected figure in the field of gynecologic oncology, Raspagliesi's work has had a profound impact on patient care, research, and education. His leadership roles and contributions to research have helped shape the way gynecologic cancers are treated and managed, influencing clinical practice and improving patient outcomes.

LEGACY AND FUTURE CONTRIBUTIONS

Francesco Raspagliesi's legacy in the field of Obstetrics and Gynecology is characterized by his dedication to patient care, leadership in gynecologic oncology, and contributions to research and education. His continued commitment to advancing the field through research, mentorship, and clinical practice ensures that his influence will be felt by future generations of gynecologic oncologists.

NOTABLE PUBLICATIONS

Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.  2024

Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes. 2024

Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.  2024

Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens. 2024

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics? (2) 2024